Literature DB >> 12039429

Quantification of the dopaminergic response in Parkinson's disease.

T Müller1, S Benz.   

Abstract

BACKGROUND: Various investigators have developed complex quantitative procedures for objective assessment of parkinsonian motor impairment, since drawbacks of rating scales are interrater variability, subjective impression, insensitivity to subtle modifications.
OBJECTIVES: To determine whether standardized performance of inserting pegs (i) differentiates between parkinsonian subjects and healthy controls and (ii) reflects quantification of the dopaminergic response with rating scales within a levodopa challenge test design. SUBJECTS AND METHODS: We used an easy-to-operate Purdue Pegboard-like apparatus, which measures the total time taken to insert 25 pegs from a rack into a series of appropriate holes by a computer to 100 ms accuracy, and simultaneous rating with part III of the Unified Parkinson's Disease Rating Scale for assessment of motor impairment in 28 idiopathic parkinsonian patients before and during a levodopa challenge test. Additionally we compared data of the instrumental task to age- and sex-matched healthy controls.
RESULTS: We found significant differences between parkinsonian subjects and controls and significant correlations to the rated severity of Parkinson's disease. Within-subject comparisons and correlation analysis demonstrated the ability of this tool to reflect scored motor improvement after intake of levodopa.
CONCLUSION: Inserting pegs provides an objective quantitative estimation of changes in motor impairment within a typical levodopa challenge test design.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12039429     DOI: 10.1016/s1353-8020(01)00010-4

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  6 in total

1.  Levodopa increases speed of alternating movements in Parkinson's disease patients.

Authors:  Thomas Müller; Sören Peters; Ali Harati
Journal:  J Neural Transm (Vienna)       Date:  2012-06-22       Impact factor: 3.575

2.  Different response to instrumental tests in relation to cognitive demand after dopaminergic stimulation in previously treated patients with Parkinson's disease.

Authors:  Thomas Müller; Ali Harati
Journal:  J Neural Transm (Vienna)       Date:  2020-02-01       Impact factor: 3.575

3.  Impaired finger dexterity and nigrostriatal dopamine loss in Parkinson's disease.

Authors:  S H Lee; M J Lee; C H Lyoo; H Cho; M S Lee
Journal:  J Neural Transm (Vienna)       Date:  2018-07-03       Impact factor: 3.575

4.  Diadochokinetic movements differ between patients with Parkinson's disease and controls.

Authors:  Thomas Müller; Ali Harati
Journal:  J Neural Transm (Vienna)       Date:  2009-11-10       Impact factor: 3.575

5.  Treatment benefit and daily drug costs associated with treating Parkinson's disease in a Parkinson's disease clinic.

Authors:  Thomas Müller; Birgit Voss; Kerstin Hellwig; Franz Josef Stein; Thorsten Schulte; Horst Przuntek
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

6.  Aerobic exercise and attention deficit hyperactivity disorder: brain research.

Authors:  Jae Won Choi; Doug Hyun Han; Kyung Doo Kang; Hye Yeon Jung; Perry F Renshaw
Journal:  Med Sci Sports Exerc       Date:  2015-01       Impact factor: 5.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.